ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1243

Clarifying Patient-Determined Barriers in Living with Systemic Lupus Erythematosus Treatment: A Qualitative Ethnographic Approach

Jerik Leung1, Deepali Sen2 and Alfred Kim3, 1Internal Medicine/Rheumatology, Washington University School of Medicine, Saint Louis, MO, 2Division of Rheumatology, Washington University School of Medicine, St. Louis, MO, 3IM/Rheumatology, Washington University School of Medicine, St. Louis, MO

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Epidemiologic methods, qualitative, quality of life, Social support and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The patient-specific experience of living with SLE is underreported. While there are data addressing factors influencing the quality of life of patients with SLE, these studies primarily derive from the perspective of the health care provider, not the patient. Changing to the patient perspective will likely improve our understanding of living with SLE, including reasons for medical noncompliance and socioeconomic differences in disease severity. Using an approach drawing from the sociological tool of ethnography, we performed extensive field observations and semi-structured interviews with a cohort (n=9) from the Lupus Clinic at Washington University School of Medicine to understand the patient perspective during the diagnosis of SLE and subsequent care.

Methods: Consented adult patients with SLE were recruited for this study during their scheduled clinic visits. We used a conventional ethnographic methodology to view the SLE experience from the patient perspective. Through long-form, semi-structured interviews (60-70 minutes) and field observations of interviewees, interviewees were encouraged to openly express their experience with SLE. 15 interviews across 9 individuals (6 individuals were interviewed twice) were performed. Interviews took place in a variety of locations including subject’s homes, cafes, public libraries, and clinic office rooms. We determined a core list of questions for each round of interviews. The initial round was based from a review of existing literature on barriers in SLE care and the authors’ clinical experience with perceived unmet needs among individuals with SLE. The second round centered on core themes which emerged from the first round of interview data and were often specific to the interviewee. Audio of interview data was recorded, transcribed, and analyzed using thematic analysis in NVivo 11.0 software.

Results: The dominant theme among patients with SLE is the deterioration of their social structure due to ambiguity and invisibility. Ambiguity derived from the protean nature of SLE disease activity, which disallowed individuals from complying with societal expectations of punctuality and reliability. Additionally, the common debilitating symptoms of SLE (e.g. chronic pain, fatigue, poor sleep quality) are largely invisible to others. Interviewees often attributed this invisibility to creating mistrust among non-SLE individuals in their social networks.

Conclusion: Ambiguity and invisibility contribute to poor quality of life in patients with SLE, with a particular negative effect on the patients’ social networks. These data have the potential to alter how providers administer SLE care. For example, loss of social structure may lead to depression and anxiety, promoting a negative view of having SLE, and driving medication and office visit noncompliance, both of which are major barriers to appropriate SLE care. Awareness of the social implications of having SLE—which are largely underaddressed by clinicians—unlock a potential to vastly improve outcomes by rethinking the doctor-patient interaction and services the health care field offer for these patients.


Disclosure: J. Leung, None; D. Sen, None; A. Kim, Kypha, Inc., 2,Exagen Diagnostics, 5,NIH/NIAMS, 2,Department of Defense, 2,Rheumatology Research Foundation, 2,Doris Duke Foundation, 2,Midwest Strategic Pharma-Academic Research Consortium, 2.

To cite this abstract in AMA style:

Leung J, Sen D, Kim A. Clarifying Patient-Determined Barriers in Living with Systemic Lupus Erythematosus Treatment: A Qualitative Ethnographic Approach [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/clarifying-patient-determined-barriers-in-living-with-systemic-lupus-erythematosus-treatment-a-qualitative-ethnographic-approach/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clarifying-patient-determined-barriers-in-living-with-systemic-lupus-erythematosus-treatment-a-qualitative-ethnographic-approach/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology